BCIQ Profiles

Company Profile Report

Stanford launches cannabinoid company Katexco for inflammatory disorders

Stanford University professors launched Katexco Pharmaceuticals Corp. (Toronto, Ontario) to develop therapies that target

Read the full 144 word article

How to gain access

Continue reading with a
two-week free trial.